miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/beta-catenin pathways | |
Zhang, Shuai; Li, Dong; Jiao, Guang-jun; Wang, Hong-liang; Yan, Ting-bin | |
刊名 | ONCOTARGETS AND THERAPY |
2018 | |
卷号 | 11页码:7967-7977 |
关键词 | miR-185 PI3K/Akt/mTOR pathway Wnt/beta-catenin pathway E2F6 Ewing's sarcoma |
DOI | 10.2147/OTT.S167771 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4572465 |
专题 | 山东大学 |
作者单位 | Shandong Univ, Qilu Hosp, Dept Orthoped, 107 Rd Wenhuaxi, Jinan 250012, Shandong, Peo |
推荐引用方式 GB/T 7714 | Zhang, Shuai,Li, Dong,Jiao, Guang-jun,et al. miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/beta-catenin pathways[J]. ONCOTARGETS AND THERAPY,2018,11:7967-7977. |
APA | Zhang, Shuai,Li, Dong,Jiao, Guang-jun,Wang, Hong-liang,&Yan, Ting-bin.(2018).miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/beta-catenin pathways.ONCOTARGETS AND THERAPY,11,7967-7977. |
MLA | Zhang, Shuai,et al."miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/beta-catenin pathways".ONCOTARGETS AND THERAPY 11(2018):7967-7977. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论